Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant

NCT03328936 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT03328936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03328936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Phase 2
Overall status
Withdrawn
Start date
September 1, 2018
Completion date
March 31, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic cell transplantation recipient, recurrent plasma cell myeloma, refractory plasma cell myeloma